期刊文献+

急性冠脉综合征患者血清sCD40L、TNF-α的变化及相关性 被引量:2

Changes and relations between serum soluble CD40L and TNF-α in patients of actue coronary syndrome
下载PDF
导出
摘要 目的探讨血清可溶性CD40配体(sCD40L)与肿瘤坏死因子-α(TNF-α)在急性冠脉综合征(ACS)中变化的意义及相关性。方法急性心肌梗死(AMI)患者45例,不稳定心绞痛(UAP)患者38例及健康体检者40例采用ELISA方法测定sCD40L及TNF-α的血清含量。结果急性冠脉综合征患者血清sCD40L在不稳定心绞痛(UAP)和急性心肌梗死组(AMI)分别为[(2.16±0.84)ng/ml,(2.93±0.99)ng/ml]显著高于健康对照组[(1.25±0.86)ng/ml(P<0.05)]。AMI组血清sCD40L水平高于UAP组,但无统计学意义。急性冠脉综合征患者血清TNF-α在AMI组为[(238.56±34.21)ng/ml]明显高于UAP组[(199.33±30.25)ng/ml(P<0.01)]和健康对照组[(132.25±29.28)ng/ml(P<0.01)]。sCD40L和TNF-α呈显著正相关(r=0.698,P<0.01)。结论急性冠脉综合征患者外周血清sCD40L和TNF-α水平升高,可能与急性冠脉综合征的发生有关,可能是动脉粥样硬化不稳定的标志,sCD40L可能通过促使TNF-α的表达而促发急性冠脉综合征。 Objective To investigate the significance and relations between serum sCD40L and TNF-α in acute coronary syndrone.Methods The study groups included 45 cases of acute myocardial infarction(AMI) ,38 unstable angina (UAP) ,and the control group had 40 healthy subjects, sCD40L and TNF-α levels were measured by Enzyme-linked immunnsorbent assay. Results sCD40L level was significantly higher in patients with acute coronary syndrome[ (2.16 ± 0.84) ng/ml and (2.93 ± 0.99) ng/ml in U AP and AMI group, respectively ] than in control group[ (1.25 ± 0.86 )ng/ml ( P 〈 0.05) ]. sCD40L level was higher in AMI group than in UAP group.But there was no statistical significance between them. The serum TNF-α level was obviously higher in patients with acute coronary syndrome[ (238.56 ± 34.21) ng/ml in AMI group] than in UAP group [ ( 199.33 ± 30.25) ng/ml ( P 〈 0.01 ) ] and control group [ ( 132.25 ±29.28) ng/ml ( P 〈 0.01 ) ]. Serum sCD40L was significantly correlated with TNF-α ( r = 0. 698, P 〈 0.01 ). Conclusion Serum sCD40L and TNF-α levels were elevated in acute coronary syndrome, which maybe relate to the oeeuranee of ACS and may serve as a potential marker of plaque stability.
出处 《中国实验诊断学》 2007年第4期459-461,共3页 Chinese Journal of Laboratory Diagnosis
关键词 急性冠脉综合征 SCD40L TNF-Α 相关性 acute coronary syndrome sCD40L TNF-α
  • 相关文献

参考文献10

  • 1Ross R.Atherosclerosis-an inllammatory disease[J].NEng J Med,1999,340:115.
  • 2Goran K,Hansson.Immune mechanism in atherosclerosis arteroscler[J].Thromb Vasc Biol,2001,21:1876.
  • 3Mach F,Schonbeck U,Sukhova GK,et al.Functional CD40ligand is expressed on human vascular endothelial cells,smooth muscle cells,and macrophages:Implication for CD40-CD40 ligand signaling in atherosclerosis[J].Proc Natl Acad Sci USA,1997,94(15):1931.
  • 4Kotowicz K,Dixon GL,Klein NJ,et al.Biological function of CD40 on human endothelial cells:costimulation with CD40 ligand and interleukin-4 selectively induces expression of vascular cell adhesion molecule-1 and Pselectin resulting in preferential adhesion of lymphocyte[J].Immunology,2001,100(3):441.
  • 5GengYL.Apoptosis of vascular smooth muscle cells indused by in vitro stimulation with interferon-r,tumor necrosis factors-α,and interleukin-Ⅰβ[J].Arterioscler Thromb VascBio,11996,16:19.
  • 6Garlichs CD,Eskafi S,Razz D,et al.Patients wiyh actue coronary syndromes express enhanced CD40 ligand/CD154 on platelets[J].Heart,2001,86:649.
  • 7Ridker PM,Rifai N,Stampfer M J,et al.Plasma Concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men[J].Circulation,2000,101 (15):1767.
  • 8彭道泉,赵水平,李毅夫,周宏年,聂赛,李江.急性冠状动脉综合征患者血浆CD40L变化及其与可溶性血管黏附分子关系[J].中华心血管病杂志,2002,30(3):141-144. 被引量:37
  • 9Nannizzi AL,AlvesVL,Phillips DR,etal.Inhibitory Effects of glycoprotein Ⅱb/Ⅲa antagonist and aspirin on the release of soluble CD40 ligand during platelet stimulation[J].Circulation,2003,107:1123.
  • 10Mach F,Schonbeck U,Fabunmi RP,et al.T Lymphocytes induce endothelial cell matrix met-Alloproteinase expression by a CD40L-dependent mechanism:implications for tubule for mation[J].Am J Pathol,1999,154(1):229.

二级参考文献10

  • 1Tsakiris DA,Tschopl M,Wolf F,et al.Platelets and cytokines in concert with endothelial activation in patients with peripheral arterial occlusive disease[].Blood Coagulation and Fibrinolysis.2000
  • 2Mach F,Schonbeck U,Sukhova GK,et al.Functional CD40 ligand is expressed on human vascular endothelial cells, smooth muscle cells, and macrophages: implication for CD40-CD40 ligand signaling in atherosclerosis[].Proceedings of the National Academy of Sciences of the United States of America.1997
  • 3Niemann-Jonsson A,Dimayuga P,Jovinge S,et al.Accumulation of LDL in rat arteries is associated with activation of tumor necrosis factoralpha expression[].Arteriosclerosis and Thrombosis.2000
  • 4Lutgens E,Cleutjens KBJM,Heeneman S,et al.Both early and delayed anti-CD40L antibody treatment induces a stable plaque phenotype[].Proceedings of the National Academy of Sciences of the United States of America.2000
  • 5Schonbeck U,Mach F,Sukhova GK,et al.CD40 ligation induces tissue factor expression in human vascular smooth muscle cells[].American Journal of Pathology.2000
  • 6Kotowicz K,Dixon GL,Klein NJ,et al.Biological function of CD40 on human endothelial cells: costimulation with CD40 ligand and interleukin4 selectively induces expression of vascular cell adhesion molecule-1 and P-selectin resulting in preferential adhesion of lymphocyte[].Immunology.2000
  • 7Cockerill GW,Rye KA,Gamble JR,et al.High-density lipoproteins inhibit cytokine-induced expression of endothelial cell adhesion molecules[].Arteriosclerosis and Thrombosis.1995
  • 8Cockerill GW,Huehns TY,Weerasinghe A,et al.Elevation of plasma high density lipoprotein concentration reduces interleukin-1-induced expression of E-selectin in an in vivo model of acute inflammation[].Circulation.2001
  • 9Mach F,Schonbeck U,Fabunmi RP,et al.T lymphocytes induce endothelial cell matrix metalloproteinase expression by a CD40Ldependent mechanism: implications for tubule formation[].American Journal of Pathology.1999
  • 10Aukrust P,Muller F,Ueland T,et al.Enhanced levels of soluble and membrane-bound CD40 ligand in patients with unstable angina-possible reflection of T lymphocyte and platelet involvement in the pathogenesis of acute coronary syndrome[].Circulation.1999

共引文献36

同被引文献33

  • 1黄磊,陆国平.外周血循环标记物检测不稳定动脉粥样硬化斑块[J].心血管病学进展,2005,26(2):116-120. 被引量:6
  • 2王芳,孙侃.CD40配体与糖尿病并发动脉粥样硬化[J].中国动脉硬化杂志,2006,14(12):1087-1089. 被引量:4
  • 3Ross R.Atherosclerosis-an inllammatory disease[J].NEng J Med,1999,340:115.
  • 4Goran K,Hansson.Immune mechanism in atherosclerosis arteroscler[J].Thromb Vasc Biol,2001,21:1876.
  • 5Ridker PM,Rifai N,Stampfer MJ,et al.Plasma Concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men[J].Circulation,2000,101(15):1767.
  • 6RossR.Atheroselerosis-An inflammatory disease[J].N Eng J Med,1999,340(2):115-126.
  • 7Schonbeck U,Sukhova GK,Shimizu K,et al.Inhibition of CD40 sig-naling limits evolution of established atheroselerosis in mice[J].Proc Natl Acad Sci USA,2000,97(35):7458-7463.
  • 8Lutgens E,Cleutjens KB,Hceneman S,et al.Both early and delayedanti-CD40L,antibody treatmentinduces a stable plaque phe-no-type[J].Proc Natl Acad Sci USA,2000,97(13):7464-7469.
  • 9Schonbeck U,Gerdes N,Varo N,et al.Oxidized low-density lip-oprotein augments and 3-hydroxy-3-methylglutaryl coenzyme Areductase inhibitors limit CD40 and CD40L expression in humanvascular cells[J].Circulation,2002,106:2888–2893.
  • 10Anand SX,Viles-Gonzalez JF,Badimon JJ,et al.Membrane-as-sociated CD40L and sCD40L in atherothrombotic disease[J].Thromb Haemost,2003,90:377–384.

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部